Wim Verreth, head of Business Development and Support at SGS Life Sciences — Clinical Research, gives us his thoughts on the changes, trends, opportunities and challenges of the year.
Manuel Leal, business development director, Idifarma, reveals what he believes have been the best opportunities, the biggest changes and most influential trends of the year.
Health systems are facing the biggest challenge in their existence: financial sustainability fuelled by the costs of prescription drugs. Here, Marisa Miraldo, associate professor at Imperial College Business School, goes into more detail…
Containment solutions for OSD are primarily concerned with the safety of those involved in producing life-saving medication — the operators. Marcus Behrens, vice president Sales Pharma Solid, Bosch Packaging Technology, goes into more detail…
Director of global managed services at Zenith Technologies, David Staunton, speaks about innovations, trends and challenges affecting the industry in 2017.
Oral solid dosage forms are still the preferred method of delivery for the pharma industry but what challenges are encountered and how does the industry solve these potential problems?
In this article, Frances Salisbury (partner) and Adam Gregory (associate) — European Patent Attorneys in the Life Sciences team at Mewburn Ellis — discuss innovation and IP of CAR-T therapies in more detail.
OSD forms are the most common dosage forms and the preferred option for many pharmaceutical products. In this Q&A we speak with Sanjay Konagurthu — Patheon, part of Thermo Fisher Scientific — about this sector.
If you are considering a quick winter getaway or some last minute sunshine over the festive period, make sure you check your meds or you may get more than you bargain for…
With the industry experiencing dramatic change, from regulatory changes to investments in capacity and the uncertainty of the political landscape, we asked several industry heads to review the opportunities, challenges and trends of 2017.
